Market Research Blog

The global Coronary Stents Market is expected to reach a valuation of US$ 51.2 Million by 2032 while the market expands at a moderate CAGR of 5.1% during 2022 to 2032. In 2022, the target market will reach an estimated value of US$ 33.36 Million. Owing to the rising geriatric population as well as the increasing prevalence of cardiovascular diseases, and lifestyle diseases like diabetes, obesity and other medical conditions, the coronary stents market will experience notable growth during the forecast period.

The rising awareness of benefits associated with stenting procedures such as significant improvement of blood flow and protection from further damage to the heart muscle contribute to the target market growth. Stenting also helps in improving the symptoms of heart disease, including angina and shortness of breath which, in turn, reduces the need for coronary bypass surgery. Hence, stenting is often preferred by surgeons as well as patients since it is a minimally invasive procedure and the post-operative recovery period is relatively short.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1993

Furthermore, a rise in the global geriatric population is leading to a larger patient pool with serious cardiovascular diseases. Again, hypertension is arising as a grave public health concern. Obesity, too, adds to this burden as one of the primary risk factors accountable for different cardiovascular diseases worldwide.

Coronary stenting is prescribed to patients who are suffering from coronary artery blockage. Though angioplasty is the first line of treatment for patients with acute coronary artery blockages while the number of patients undergoing stenting has been increasing steadily over the last ten years. This is owing to the rise of outpatient coronary stenting procedures, which shortens long hospital stays. Additionally, a large number of cardiologists prescribing stenting procedures for patients with CAD is a prime factor that will likely fuel revenue growth of the coronary stent market during the forecast period.

“Increasing cases of lifestyle diseases like obesity and diabetes often result in heart issues which, in turn, supplements the global growth of the coronary stents market over the forecast period,” says an FMI analyst.

Ask An Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1993

Key Takeaways:

• Rising awareness of the benefits associated with stenting will strengthen market prospects.
• Prevalence of alternative treatment methods, product failure, and recalls are certain factors that may hamper market growth.
• Growing cases of coronary artery diseases propel the coronary stent market in the United States.
• Favorable government support for the healthcare sector will present new market opportunities in China.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1993

Competitive Landscape

Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medica among others are some of the major players in the coronary stents market profiled in the full version of the report.

Key market players are focusing on product upgradation and offering new features to meet the rising consumer demand. These organizations are employing strategies like new product releases, partnerships, collaborations, mergers, and acquisitions to gain a competitive advantage.

More Insights into Coronary Stents Market Report

In its latest report, FMI offers an unbiased analysis of the global coronary stents market, providing historical data from 2016 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of product type (drug eluting stent (DES), bare metal stent (BMS), bioresorbable vascular stent (BVS)), raw material (cobalt chromium, stainless steel, platinum-chromium, nickel-titanium, polymer), end user (hospitals, ambulatory surgical centers, cardiac catheterization laboratories), and region.

Use promo code >> FMITODAY to get flat 20% discount

According to the latest FMI reports, based on region, China’s coronary stent market will likely exhibit an impressive growth rate during the observation period due to favorable government support for the healthcare sector. The coronary stent market in the United States is anticipated to demonstrate substantial growth over the forecast period. The rising prevalence of coronary artery disease is spurring the demand for interventional cardiology treatment in this country. Sedentary lifestyles, smoking, poor dietary habits, and pollution often contribute to increasing cases of cardiovascular diseases. All of these factors are expected to drive the demand for the target market during 2022-2032.

Key Segments Covered in the Coronary Stents Industry Analysis

By Product:

• Drug Eluting Stent (DES)
• Bare Metal Stent (BMS)
• Bioresorbable Vascular Stent (BVS)

By Raw Material:

• Cobalt Chromium
• Stainless Steel
• Platinum – Chromium
• Nickel – Titanium
• Polymer

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

According to estimates, the Positron Emission Tomography (PET) Scanners Market will be worth US$ 1.3 billion in 2023 and US$ 2.1 billion by 2033. Throughout the forecast period, the market is anticipated to expand at a CAGR of 5.3%. The market for positron emission tomography (PET) scanners is driven by a number of variables, including:

The global Positron Emission Tomography (PET) Scanners Market is expected to grow at a stable CAGR of around 5.1% from 2021 to 2031. The global market reached a valuation of around US$ 1.2 Bn in 2021. According to the estimations by Future Market Insights, full-ring PET scanners held a substantial share of over 84.3% in 2020. The comparative analysis and market growth rate of the global positron emission tomography (PET) scanners market, included advancements in incorporated silicon photomultiplier (SiPM) technology within product specifications, and new innovations in the TSPO PET tracers.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1333

According to the historic analysis, the demand for PET scanners surged at a stagnant CAGR of 3.4% between 2016 and 2020 with sales representing around 4.4% of the overall US$ 24.5 Bn medical imaging market in 2020. Surging demand in the radiopharmaceuticals sector along with the integration of computed tomography with PET, and advancements in hybrid imaging systems are anticipated to boost the market. In contrast to this backdrop, the present positron emission tomography (PET) scanners market is anticipated to extend at a stable CAGR of 5.1% CAGR over the assessment period.

The comparative analysis and market growth rate of the global Positron Emission Tomography (PET) scanners market are studied by Future Market Insights. According to the FMI analysis, the global positron emission tomography (PET) scanners market expects to rise by 01 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 Projected value, the market during the H1-2022 outlook period will show a dip of 40 BPS.

Key Takeaways

• The process incorporates the visualization of biochemical changes in the body, including the strong metabolism of the heart muscle. These efficient scanners employ a type of nuclear medicine process in order to accurately measure the metabolic activity of the body tissues and cells. It is a combination of nuclear medicine and biochemical analysis. They are mostly used in patients with heart or brain conditions, and cancer.
• The surging adoption of PET and X-ray transmission computed tomography (CT) scans is expected to propel growth in the market over the upcoming years. This innovative technology is predicted to reduce acquisition time, and provides precise attenuation correction and fusion imaging, resulting in high diagnostic sensitivity and specificity.
• Furthermore, the combination of PET and CT helps in improving the staging of disease by defining prognostic and treatment monitoring capabilities of the functional and metabolic information given by conventional nuclear imaging techniques.

Ask Us Your Questions About This Report@ https://www.futuremarketinsights.com/ask-question/rep-gb-1333

• Most PET scanning products are used to perform fluorodeoxyglucose (FDG) as it has the capability to capture tissue glucose metabolism and increase its parameters. Although, fluorodeoxyglucose consists of some shortcomings such as low specificity. Additionally, several potential radiotracers are under investigation to address the unmet clinical needs of diagnosis of diseases.
• In order to tackle such diseases, various manufacturers are launching new products that come with higher sensitivity concerning metabolic activity to achieve detailed scans. Players are also investing in mergers and acquisitions to improve their product portfolios.
• The market is expected to comprise mandatory equipment registered in several countries, regulatory requirements for development, and reimbursement changes. The market is highly influenced by the advances in minimally invasive surgical procedures and the establishment of new patented products.
• Over the recent years, the market observed a surge in the BPS values owed to the potential benefits of digital PET scanners over conventional analog scanners attributed to their improved image quality, thus promoting greater adoption. In addition to that, the market experienced change within the BPS values owing to the reduction in the number of elective surgeries as well as the emergence of telehealth during the advent of the COVID-19 pandemic.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1333

Competitive Landscape

Key market players are concentrating on a novel and innovative approaches for the development of positron emissions tomography scanners driven by emerging cases of infectious diseases and the lack of advanced methods for efficient detection. An expansion of the production facility along with new product launches and approvals are projected to further strengthen the growth of the market.

More Insights into the Positron Emission Tomography (PET) Scanners Market

The U.S. is anticipated to dominate the North American market as it accounted for around 94.4% of the total market share in 2020. Due to the rising prevalence of cancer in the country, an underpinning need for advanced PET scanners, thereby creating sales prospects in the market.

Request Discount@ https://www.futuremarketinsights.com/checkout/1333

Competitive Landscape

Key players focus on novel and innovative approaches to develop positron emission tomography scanners. Production facility expansions, new product launches, and product approvals can strengthen their market presence

Some of the prominent players in the market are:

• G.E. Healthcare
• Toshiba Corporation
• Koninklijke Philips N.V.
• Siemens Healthineers
• Hitachi Medical Corporation
• Positron Corporation
• Mediso Ltd.
• Yangzhou Kindsway Biotech Co., Ltd

Positron Emission Tomography (PET) Scanners Market by Category

By Product Type:

• Full-ring PET Scanner
• Partial-ring PET Scanner

By Application:

• Oncology
• Cardiology
• Neurology
• Others

By Detector Type:

• Bismuth Germanium Oxide
• Lutetium Oxyorthosilicate
• Gadolinium Oxyorthosilicate
• Lutetium Fine Silicate
• Lutetium Yttrium Orthosilicate

By End User:

• Hospitals
• Diagnostic Centers
• PET Centers
• Research Institute

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

By the end of 2022, the Special Purpose Needles Market is anticipated to be worth US$ 12.6 billion, and it is projected to grow at a CAGR of 7.9% from 2022 to 2032. By the end of 2032, the market is anticipated to be valued at around $27.0 billion USD. The market’s largest region, North America, with a share of around 34.5% in 2021.

The global Special Purpose Needles Market is projected to be valued at US$ 17,261.5 million by the end of 2026, registering a CAGR of 7.4% during the forecast period (2016–2026). In a new report titled “Special Purpose Needles Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”, Future Market Insights delivers key insights on the factors and trends impacting the global special purpose needles market over a 10-year forecast period (2016–2026).

The market for special purpose needles is witnessing steady growth across the globe owing to an increasing geriatric population. According to analysts at Future Market Insights, “Increasing prevalence of diabetes and infectious diseases and increasing incidence of cancer and spine disorders across the globe are the primary factors driving the growth of the global special purpose needles market.”

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-583

Availability of better reimbursement options for some types of special purpose needles in developed economies is likely to propel demand for special purpose needles over the forecast period. A key trend witnessed in the global special purpose needles market is the development of advanced techniques in the production of special purpose needles to facilitate enhanced patient safety and comfort. However, rise in awareness on needle free injections and risks associated with injections are major factors expected to hamper the overall growth of the special purpose needles market over the forecast period.

The global special purpose needles market can be segmented on the basis of product type (Fine Aspirating Needles, Biopsy Needles, Hypodermic Needles, Pen Needles, Suture Needles, IV Catheter Needles, Implantation Needles, Dental Needles, Ophthalmic Needles, Blood Collection Needles, Spinal Anaesthesia Needles, Epidural Needles, AV Fistula Needles, Cannula Needles); application (Sample Collection, Drug Delivery); and distribution channel (Hospital Pharmacies, Private Clinics,   Retail Pharmacies and Drug Stores, E-Commerce).

Segmentation highlights

• The Pen Needles product type segment is expected to gain popularity over the forecast period, driven by increasing global adoption of small sized needles for insulin injections. The Pen Needles product type segment is estimated to reach a valuation of US$ 644.3 Mn by the end of 2016, registering a CAGR of 9.1% over the forecast period.
• The Sample Collection application segment is estimated to register a CAGR of 7.7% while the Drug Delivery application segment is expected to register a CAGR of 7.1% during the forecast period.
• Demand for special purpose needles over the forecast period is expected to be the highest in the Hospital Pharmacies distribution channel segment, which is expected to register a CAGR of 8.5% in terms of value.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-583

Regional forecast

The North America market has been estimated to dominate the special purpose needles market while the market in APEJ is expected to be the fastest growing in terms of revenue growth. The markets in North America, Western Europe, and APEJ are estimated to collectively hold 74.7% market share of the global special purpose needles market in 2016.

Vendor insights

Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, Boston Scientific Corporation, Novo Nordisk A/S, Argon Medical Devices, Inc., Stryker Corporation, NIPRO Medical Corporation, Cook Medical, and SERAG-WIESSNER GmbH & Co. are some of the major companies operating in the global special purpose needles market. These companies are adopting innovative strategies to bring in improvements to their product design and are initiating advanced R&D activities and market consolidation to strengthen market foothold and expand customer base.

Market segmentation By Product Type

• Fine Aspirating Needles
• Biopsy Needles
• Hypodermic Needles
• Pen Needles
• Suture Needles
• IV Catheter Needles
• Implantation Needles
• Dental Needles
• Ophthalmic Needles
• Blood Collection Needles
• Spinal Anaesthesia Needles
• Epidural Needles
• AV Fistula Needles
• Cannula Needles

Ask For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-583

By Application

• Sample Collection
• Drug Delivery

By Distribution Channel

• Hospital Pharmacies
• Private Clinics
• Retail Pharmacies and Drug Stores

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

The global Regenerative Medicine Market is anticipated to register a phenomenal growth of 23.9% with an evaluation of around US$ 9.9 Billion by the end of the year 2022 and is further expected to enjoy an estimation of US$ 85.3 Billion by the year 2032.

According to the historical analysis done by Future Market Insights, tissue engineering by therapy type led the market growth with a share of about 43.1% in the year 2021 within the global regenerative medicine market. The targeted therapeutic market is expected to generate a revenue of around US$ 100.9 Bn by contributing about 8.3% to the global regenerative medicine market.

Regenerative medicine is widely accepted in the healthcare sector in order to counter the unmet medical needs in the field of cardiology, wound and injury musculoskeletal, oncology, dental, ophthalmology, hepatological diseases, and inflammatory & autoimmune diseases. The solutions regarding clinical and pre-clinical outcomes for allogeneic cell therapy are promising.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1326

Key Takeaways

• An opportunistic outlook is presented by the regenerative medicine market in the future owing to the beneficial outcomes of regenerative medicine. Several biopharmaceutical companies have initiated the establishment of regenerative medicine-specific regulatory processes which consist of guidelines, a quicker approval pathway, and also quality control for conducting clinical trials. Therefore, a massive boom in the regenerative medicine market is witnessed over the projection years.
• The industry is keeping into account some of the prominent factors such as reduced manufacturing cost, improvement in distribution systems, and expansion. Technological advances taking place in the field of life sciences date back several years ago. The gene editing technology applied in regenerative medicine manufacturing assists in yielding quality results and avoids challenges such as immune rejection.
• In order to treat a wide spectrum of diseases, pluripotent stem cell (PSC)-derived therapies are beneficial and surging rapidly over the years. These factors are acting as driving factors for the regenerative medicine market over the assessment years.
• The research and development sector is drastically making efforts to develop an innovative therapy type through modifications and implementing new discoveries in the field of cell therapy and applying gene editing tools that help in making the overall process of discovery easier. Since the methodology used is unique and determines steps for instance use of universal donor cells which establishes successful engraftment in autologous transplantation. The aforementioned factors are responsible for growth in the market.
• The growing prevalence of chronic diseases paired with the surge in wounds and injuries among the ever-growing population is anticipated to surge the regenerative medicine market. The approval of these products is governed by various regulatory laws, including pharmaceutical affairs law, technical guidance for the quality of regenerative medicine products, regulation (EC) 1394/2007, and others because these therapy types have a substantial impact on health.
• The regeneration medicine market has a direct link with the prevalence of diseases in the increasing population. Since these stem cell-based therapies have a vital impact on health thereby, the approval of these therapies including the use of regenerative medicine is governed by several standard organizations such as the Food and Drug Administration (FDA), and European Medicines Agency (EMA), among others.

Ask An Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1326

Competitive Landscape

Various key players in the regeneration medicine market are focusing on expanding their consumer base in order to meet consumer demands. Since the overall market is fragmented, prominent companies in the market are implementing methods such as a divestiture, partnerships and collaborations, and new therapy launches.

More Insights into the Regenerative Medicine Market

The U.S. is expected to dominate the global regenerative medicine market as it is accounting for a total of about 24.2% in 2021 and is anticipated to experience a similar growth throughout the forecast period.

The account of an aging population, the widespread adoption rate of regenerative medicines, and the importance of chronic diseases are contributing factors boosting the regenerative medicine market.

Australia held a market share of around 12.9% in the global regenerative medicine market in 2021. Having a robust regulatory framework, the presence of such facilities has encouraged several ventures to invest in and look for new opportunities in Australia.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1326

Key Companies Profiled

• 3M
• Allergan plc
• Amgen, Inc.
• Aspect Biosystems
• bluebird bio
• Kite Pharma
• Integra LifeSciences Holdings Corporation
• MEDIPOST Co., Ltd.
• Anterogen Co., Ltd.

Key Market Segments Covered In Regenerative Medicine Industry Research

By Therapy type:

• Cell Therapy
  • Autologous Cell Therapy
  • Allogenic Cell Therapy
• Stem Cell Therapy
  • Allogeneic Stem Cell Therapy
  • Autologous Stem Cell Therapy
• Tissue-engineering
• Gene Therapy

By Application:

• Wound Care
• Musculoskeletal
• Oncology
• Dental
• DMD (Duchenne Muscular Dystrophy)
• Hepatological Diseases
• Inflammatory & Autoimmune Diseases
• Other Therapeutic Applications

Use promo code >> FMITODAY to get flat 20% discount

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

The Antibodies Market is anticipated to develop at a CAGR of 13.4% from 2023 to 2033, and it is anticipated to reach US$ 236.9 billion in 2023. By 2033, it is expected that the antibody industry would be worth US$ 834.2 billion. The total market value of the antibodies sector, at US$ 597.3 Billion, is represented by the absolute dollar growth of the global market.

A renowned provider of market research and competitive data, Future Market Insights, predicts that by the end of 2031, the antibodies market will have grown by a factor of 21 and will be worth more than US$ 601.614 billion.

1. Hoffmann-La Roche Ltd., AbbVie Inc., Johnson & Johnson Services, Inc., Amgen Inc., and Bristol-Myers Squibb Company are among the market’s top competitors, according to FMI surveys. Three out of every four sales of antibodies worldwide are accounted for by these big players.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1330

About 4% of the world’s population is afflicted by an autoimmune disease, according to reports from the National Stem Foundation (NSCF). Diabetes, MS, Crohn’s disease, and rheumatoid arthritis are the most prevalent autoimmune illnesses. The market for antibodies is predicted to be extremely in demand as a result of these chronic disorders.

Key Insights

Antibodies are essential for treating medical conditions including autoimmune diseases, cancer, and several types of neurological diseases. Immunoglobulin (IG) is a type of antibody that is used for the prevention of lower respiratory tract infections and diseases caused by the vaccinia virus. Rising cases of viral infection will drive the demand for antibodies.

The prevalence of autoimmune diseases is on the rise, and they also have the potential to act as a host for multiple chronic ailments. Owing to these factors, the demand for antibodies is forecast to increase in upcoming years.

The COVID-19 pandemic boosted the demand for antibodies as patients suffering from COVID-19 were highly susceptible to contracting various other ailments and, in some cases, triggered autoimmune diseases in the patient.

Novel biosimilar antibody manufacturers are slashing their prices to compete with branded antibody manufacturers, especially in the European market. With the expiration of patents of renowned products, a boost in demand for biosimilar antibodies can be expected in upcoming years.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1330

A reasonable hike in research and development activities among healthcare and pharmaceutical market leaders are working towards developing effective and economical antibodies and biosimilar antibodies, propelling growth in the market.

Parkinson’s and Sclerosis diseases are on the rise among older people which is a key factor fueling the demand for antibodies. There is an urgency to develop cheap and personalized medicines, novel and effective treatments, and advanced therapeutics in middle-income countries which is expected to positively influence the sales of antibodies.

The widespread application of antibodies in chronic disease treatment is accelerating which is predicted to create scope for market expansion in the near future.

Competitive Landscape

Novartis AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi SA, Eli Lilly, and Co. are some of the key companies profiled in the full version of the report.

Future Market Insights (FMI) has found that market players are working towards developing new antibodies to treat cancer and other diseases. They are also researching to create long-acting antibody drugs to reduce healthcare costs.

In order to gain a competitive edge in the antibodies market, key players are developing oral and noninvasive treatments using antibodies to treat chronic ailments. Strategic mergers and acquisitions for portfolio expansion are in the cards as well.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1330

More Insights into Antibodies Market

The United States is considered the dominant market in the North American region owing to modern healthcare infrastructural facilities and the presence of leading market players in the country. An increase in government funding and elevated purchasing power is expected to drive growth in the market.

The GCC countries led by Saudi Arabia are increasingly focusing on research and development on early diagnosis and screening of cancer to elevate the survival rate and chance of successful treatment. The contribution of antibodies is significant in this research. Hence, propelling growth in the market.

The development and production of antibodies are on a rise in China and are expected to surge significantly owing to increasing government investment in drugs and development coupled with growing awareness about various medical ailments like rheumatoid arthritis, cancer, and infections.

The Indian antibodies market is anticipated to grow at a rapid pace owing to rising cases of cancer and cardiovascular diseases along with the development of the healthcare system in the country. According to the reports of the Global Cancer Observatory, 1.322 million new cancer cases were registered in India in 2020, while 2.72 million people had cancer for 5 years. A surge in cancer patients will drive the demand for monoclonal antibodies for cancer treatment.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭@ https://www.futuremarketinsights.com/checkout/1330

Key Segments Covered in Antibodies Market Study

By Disease Indication

• Cardiovascular diseases
• CNS disorders
• Cancer
• Autoimmune Disorders

By Product Type

• Monoclonal antibodies
• Polyclonal antibodies
• Antibody-drug complexes (ADCs)

By End User

• Hospitals
• Long-term Care Facilities
• Research institutes

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, U.S., and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs